Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / *W EXP 02/18/201
-
Total 13F shares
-
990,043
-
Share change
-
-93,041
-
Total reported value
-
$30,000
-
Price per share
-
$0.03
-
Number of holders
-
6
-
Value change
-
-$16,297
-
Number of buys
-
1
-
Number of sells
-
5
Institutional Holders of ONCOBIOLOGICS INC - *W EXP 02/18/201 (ONSIW) as of Q4 2017
As of 31 Dec 2017,
ONCOBIOLOGICS INC - *W EXP 02/18/201 (ONSIW) was held by
6 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
990,043 shares.
The largest 6 holders included
Cormorant Asset Management, LLC, venBio Select Advisor LLC, Marshall Wace North America L.P., PointState Capital LP, SABBY MANAGEMENT, LLC, and Monashee Investment Management LLC.
This page lists
6
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.